Selecting a Tyrosine Kinase Inhibitor in Chronic Myeloid Leukemia Case Study OncLive 9:08 8 years ago 949 Далее Скачать
Case 3: TKI Therapy and Treatment Monitoring in CML Targeted Oncology 7:54 5 years ago 250 Далее Скачать
Selecting EGFR Tyrosine Kinase Inhibitors for EGFR-Mutant Lung Cancer Targeted Oncology 0:52 4 years ago 465 Далее Скачать
HCC Whiteboard #3: The Management of Adverse Events of Tyrosine Kinase Inhibitors HMP Education 3:12 6 years ago 2 391 Далее Скачать
The Role of Tyrosine Kinase Inhibitors and mTOR Inhibitors Kidney Cancer 41:21 9 years ago 4 339 Далее Скачать
Tyrosine Kinase Inhibitors (TKIs) - Imatinib (Gleevec) - Pharmacology - CML and ALL Medicosis Perfectionalis 4:20 6 years ago 94 296 Далее Скачать
Highlights From Bruton’s Tyrosine Kinase Inhibitors HMP Education 1:13:43 1 year ago 480 Далее Скачать
Cost-benefit considerations for TKI selection in CML VJHemOnc – Video Journal of Hematology & HemOnc 1:39 1 year ago 156 Далее Скачать
Second-Generation Tyrosine Kinase Inhibitors in Chronic Myelogenous Leukemia OncLive 5:34 10 years ago 1 009 Далее Скачать
Randomised controlled trial of first-line tyrosine-kinase inhibitor (TKI) versus inte... | RTCL.TV Medicine RTCL TV 0:25 1 year ago 5 Далее Скачать
The future of tyrosine kinase inhibitors for melanoma and open questions VJOncology 2:23 8 years ago 373 Далее Скачать
Webinar Wednesdays - Tyrosine kinase inhibitors & PKD PKDFoundation 1:00:31 3 years ago 552 Далее Скачать
"TKIs: Tyrosine Kinase Inhibitors & Neuroendocrine Tumors" • 2024 LACNETS Event • March 29, 2024 LACNETS 1:18:47 8 months ago 707 Далее Скачать
Update on the efficacy and safety of tyrosine kinase inhibitors for chronic myeloid leukemia VJHemOnc – Video Journal of Hematology & HemOnc 2:03 9 years ago 181 Далее Скачать
